Brain Imaging and Retreatment Study of Persistent Lyme Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 1999

Conditions

Lyme DiseaseLyme Neuroborreliosis

Interventions

DRUG

ceftriaxone

Trial Locations (1)

Columbia Presbyterian Medical Center, New York

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00037479 - Brain Imaging and Retreatment Study of Persistent Lyme Disease | Biotech Hunter | Biotech Hunter